
Search
Dr Angela Sester
Person
Dortmund University under Prof. Dr. Markus Nett, where she mainly investigated myxobacteria for new drug classes. As a postdoc at the TU Dresden with Prof. Dr. Tobias A. M. Gulder, the research focus shifted
Read moreQinyuan Liu
Person
generative models to design novel protein sequences and applies explainable AI (XAI) techniques to Drug-Target Interaction (DTI) models. These efforts aim to identify critical protein residues, enabling
Read morePublications
Page
Monoclonal Human Alveolar Epithelial Cell Line (“Arlo”) with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections Read more Persicamidines—Unprecedented Sesquarterpenoids with Potent
interesting enzymes usable in the lab, and applying them for efficient biocatalytic or chemo-enzymatic drug synthesis. Overall, our research not only enables efficient exploration of natural products, but also
Read moreICA 2025
Page
is understanding natural product functions in the context of the microbiome, (chemo)synthetic and drug design approaches towards anti-infectives and translational aspects into industry. Location: The
Pulmonary drug delivery
Publication
Henning A,
Hein S,
Schneider M,
Bur M,
Lehr C
(2010)
Book, 197, 10.1007/978-3-642-00477-3_6
Book, 197, 10.1007/978-3-642-00477-3_6
pH-triggered drug release from biodegradable microwells for oral drug delivery
Publication
Nielsen L,
Nagstrup J,
Gordon S,
Keller S,
Østergaard J,
Rades T,
Müllertz A,
Boisen A
(2015)
Biomedical microdevices, 17, 3, 10.1007/s10544-015-9958-5, 25981751
Biomedical microdevices, 17, 3, 10.1007/s10544-015-9958-5, 25981751